You are correct that ESSENSE is not the same exon skipping trial, but I did read somewhere that the FDA wanted the ESSENSE trial started before they will give the verdict on AA for Eteplirsen. So, when the company makes an announcement of the start of ESSENSE, look for the FDA decision shortly thereafter.
As mentioned, I am long on this stock and don't want to see a massive nose-dive. But I have seen this too many times with biotech stocks and heavy-hitting, deep-pocket shorts. They can and do move the stock in a downward direction setting off a chain reaction of selling, and prelude to this is massive purchases of Put options...which we are seeing.
So, I'm just saying if the shorts play their games on Friday with a bear raid, then have some dry powder on the sidelines ready to pick up shares on the cheap.
I am long on this stock, but it looks like a monster bear raid is setting up for Friday. There has been no news from the company, but $10 Put options have been going through the roof over the last 2 trading sessions, and there is a whopping 51,000 contracts in Open Interest. Keep some dry powder ready for the drop sometime Friday afternoon.
Dude - It's easy to stand on the sidelines and call a company and investors nasty names, but are you willing to put your money where your mouth is and short this stock? You do realize that hitting a confirmatory dystrophin production of 1% of normal just may send this stock to $40 after announcement, don't you? Blast away like a coward with no skin in the game if you want, but if Etep does in fact get accelerated approval, it would be interesting to see if you announce your failure and politely leave this message board.
You may have noticed that the folks who pollute this Message Board are the folks that have absolutely no skin in the game. We all know the stock will drop to $4 if Eteplirsen shows zero production of dystrophin from the baseline, and will rise to $40 if dystrophin production hits or exceeds 1%.
It's just sad when people have nothing better to do than troll the message boards and spew out as much negativity as they can muster, knowing that most investors are bullish hoping for the best for patients with debilitating diseases.
Like you mentioned, I find it hard to imagine that a drug that repeatedly shows dystrophin production, will all of a sudden show zero production at 48 weeks. I don't like to see people lose money, but I do LOVE IT when shorts get burned badly.